Davutamig
Davutamig (REGN-5093) is a humanIgG4-kappa, anti-MET bispecific antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic agent[1].
Product Specifications
CAS Number
[2648058-48-2]
Product Name Alternative
REGN-5093
UNSPSC
12352203
Target
C-Met/HGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/davutamig.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Davutamig]
Molecular Weight
(144.62 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 4, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
041039-ML750 100 µL
RHOXF1, ID (RHOXF1, OTEX, PEPP1, Rhox homeobox family member 1, Ovary-, testis- and epididymis-expressed gene protein, Paired-like homeobox protein PEPP-1) (MaxLight 750) discontinued
Ask
View Details